G2 served as exclusive sell-side advisor to Biotron Laboratories and Talus Minerals Company on its sale to Aceto
Biotron Laboratories, LLC (“Biotron”) and Talus Minerals Company (“Talus”), collectively (“the Company”), is a leading producer of premium, food-like speciality minerals and customized mineral solutions serving the nutrition supplement industry. The Company serves a diverse mix of customers that span the globe and provides exceptional service and high-quality products to the greater nutritional and dietary ingredients markets. Headquartered in Ogden, UT, the Company operates with a deeply ingrained, service-first culture.
Biotron and Talus, longstanding leading producers of specialty mineral chelates and complexes serving customers globally, organically built a highly scalable platform with premium products and a customer-driven approach. As part of the Companys’ long-term growth strategy, management sought a strategic partner to support its continued growth and expansion.
G2 Capital Advisors, LLC (“G2”) was engaged by Biotron and Talus as its exclusive sell-side advisor. G2 led a highly targeted, strategic, and efficient sell-side transaction process focused on identifying the right partner for the Company to further accelerate the growth of the platform.
In March 2022, the transaction was successfully executed through a sale to Aceto, the provider of choice for differentiated specialty ingredients in the life sciences and advanced technology end markets. Aceto is a portfolio company of New Mountain Capital.
“Through this process with G2 we’ve learned more about the inner workings of our own business than we imagined was left to learn. We leaned on their team for insight and advice and were introduced to a broad array of qualified parties. With the support of G2’s team of seasoned experts we achieved an outcome that exceeded our expectations. Via G2 we have found in Aceto the right fit for ensuring continued success and a growth platform for our business, our customers, and our team,” said Gameil Fouad, PhD, President, Biotron Laboratories, LLC.
“The partnership between the Company and Aceto will continue to fuel the growth of its platform and allow for the expansion of their commercial reach on an accelerated timeline. We are thrilled to have led our client through a successful transaction and are excited to watch these two groups continue to flourish in this new partnership,” said Victoria Arrigoni, Managing Director and Head of Industrials & Manufacturing at G2 Capital Advisors.
G2 Capital Advisors provides M&A, capital markets, and restructuring advisory services to the middle market. We offer integrated, multi-product and sector-focused services by pairing highly experience C-level executives with specialist investment bankers. We aspire to be the trusted advisor of choice to our clients including corporations and institutional investors. For more information, visit www.g2cap.com
ABOUT BIOTRON LABORATORIES AND TALUS MINERAL COMPANY:
Biotron Laboratories and Talus Mineral Company, founded in 1979 and 2014, respectively, are affiliated entities that in partnership manufacture and supply leading speciality minerals and nutritional ingredients to global markets. Biotron provides clients excellent customer service, agile processing capabilities, and proprietary production methods to deliver the highest quality ingredients with speed and certainty. The Company provides over 250 products including mineral complexes, custom blends, fortified blends, and chelates, which include magnesium-based, zinc-based, calcium-based and iron-based products. Products include halal, kosher, vegan and organic certified options. The Company’s manufacturing operations are located in Centerville, Utah and Ogden, Utah. For more information visit www.biotronlabs.com and www.talusminerals.com
Aceto is the provider of choice for differentiated specialty ingredients in the life sciences and advanced technology end markets. With business operations in 10 countries, Aceto manufactures and supplies more than 3,000 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries. In the last two years, Aceto has made seven acquisitions including Biotron, which has expanded its manufacturing, R&D, and portfolio offerings, transforming the company into a worldwide supplier of critical ingredients with a robust manufacturing footprint. Aceto’s global operations, including a significant presence not eh ground in China, India, Europe and North America, enable the companys’ deep worldwide sourcing and regulatory capabilities. Aceto is well positioned to innovate new solutions, ensure quality and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide. For more information visit, www.aceto.com
CONTACTS ON THIS DEAL:
Victoria Arrigoni: MD, Head of Industrials & Manufacturing, T: 781.604.9005 E: [email protected]
Mike Williams: Director, Industrials & Manufacturing, T: 917.523.2164 E: [email protected]
Noah Johnson: Sr. Analyst, T: 717.598.8558 E: [email protected]
Ted Malpiede: Sr. Analyst, T: 781.752.6001 E: [email protected]
Matt Ball: Sr. Associate, T: 978.914.4421 E: [email protected]